Elevated plasma CXCL9 and CHI3L1 prior to HCT predict post-HCT lung complications in children.

Saved in:
Bibliographic Details
Title: Elevated plasma CXCL9 and CHI3L1 prior to HCT predict post-HCT lung complications in children.
Authors: Walker H; Children's Cancer Centre Royal Children's Hospital Parkville VIC Australia.; Department of Paediatrics University of Melbourne Parkville VIC Australia.; Murdoch Children's Research Institute Parkville VIC Australia., Gubbels L; Murdoch Children's Research Institute Parkville VIC Australia., Haeusler GM; Department of Paediatrics University of Melbourne Parkville VIC Australia.; Murdoch Children's Research Institute Parkville VIC Australia.; Infection Diseases Unit, Department of General Medicine Royal Children's Hospital Parkville VIC Australia.; Department of Infectious Diseases Peter MacCallum Cancer Centre Melbourne VIC Australia.; NHMRC National Centre for Infections in Cancer, Sir Peter MacCallum Department of Oncology University of Melbourne Parkville VIC Australia.; The Paediatric Integrated Cancer Service Parkville VIC Australia., Shanthikumar S; Department of Paediatrics University of Melbourne Parkville VIC Australia.; Murdoch Children's Research Institute Parkville VIC Australia.; Respiratory and Sleep Medicine Royal Children's Hospital Parkville VIC Australia., Hanna D; Children's Cancer Centre Royal Children's Hospital Parkville VIC Australia.; Department of Paediatrics University of Melbourne Parkville VIC Australia.; Murdoch Children's Research Institute Parkville VIC Australia.; The Paediatric Integrated Cancer Service Parkville VIC Australia., Cole T; Children's Cancer Centre Royal Children's Hospital Parkville VIC Australia.; Department of Paediatrics University of Melbourne Parkville VIC Australia.; Murdoch Children's Research Institute Parkville VIC Australia.; Allergy and Immunology Royal Children's Hospital Parkville VIC Australia., Neeland MR; Department of Paediatrics University of Melbourne Parkville VIC Australia.; Murdoch Children's Research Institute Parkville VIC Australia.
Source: Clinical & translational immunology [Clin Transl Immunology] 2025 Dec 16; Vol. 14 (12), pp. e70064. Date of Electronic Publication: 2025 Dec 16 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons Australia, Ltd. on behalf of Australasian Society for Immunology Inc Country of Publication: Australia NLM ID: 101638268 Publication Model: eCollection Cited Medium: Print ISSN: 2050-0068 (Print) Linking ISSN: 20500068 NLM ISO Abbreviation: Clin Transl Immunology Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first